Holen Sie sich die Stockscreener-App
80.60
1.44%
-1.18
Ionis Pharmaceuticals Inc Aktie (IONS) Neueste Nachrichten
Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) Director Sells 5,000 Shares of Stock - MarketBeat
Insider Sell: B Parshall Sells 5,000 Shares of Ionis Pharmaceuti - GuruFocus
Ionis Pharmaceuticals director Parshall sells $413,588 in stock By Investing.com - Investing.com Canada
Ionis Pharmaceuticals EVP Swayze sells $1.27 million in IONS stock By Investing.com - Investing.com Canada
Severe Hypertriglyceridemia Market: High-Growth Opportunities for Investors to 2034DelveInsight - openPR.com
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Yahoo Finance
Ionis to hold fourth quarter and full year 2025 financial results webcast - Caledonian Record
Ionis Pharmaceuticals (IONS) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Ionis Pharma CEO Monia sells $2.52m in shares By Investing.com - Investing.com Canada
Ionis Pharma CEO Monia sells $2.52m in shares - Investing.com
Ionis Pharmaceuticals (NASDAQ:IONS) CEO Brett Monia Sells 29,430 Shares - MarketBeat
Ionis Pharmaceuticals (IONS) Valuation Check As Dawnzera Approval And Other Milestones Support Growth Prospects - Sahm
Candriam S.C.A. Has $39.99 Million Stock Position in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Stock Recap: Why is Ionis Pharmaceuticals Inc stock going upWeekly Market Report & Consistent Income Trade Ideas - baoquankhu1.vn
Wealth Enhancement Advisory Services LLC Sells 15,476 Shares of Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 6 Analysts - Benzinga
Ionis Pharmaceuticals (IONS) Sees Price Target Raised by Piper S - GuruFocus
More Rivalry With Ionis In A Potentially ‘Transformational’ Year For Arrowhead - Citeline News & Insights
Ionis Pharmaceuticals stock hits 52-week high at 86.31 USD By Investing.com - Investing.com South Africa
Ionis Regulatory Wins Highlight Growing Rare Disease Revenue Potential - Sahm
Ionis Pharmaceuticals (NASDAQ:IONS) Hits New 1-Year HighWhat's Next? - MarketBeat
Ionis Pharmaceuticals stock hits 52-week high at 86.31 USD - Investing.com
Dawnzera Approval And Pipeline Wins Could Be A Game Changer For Ionis Pharmaceuticals (IONS) - Yahoo Finance
C WorldWide Group Holding A S Sells 24,000 Shares of Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Insider Sell: C Bennett Sells 85,089 Shares of Ionis Pharmaceuti - GuruFocus
Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells $7,056,430.77 in Stock - MarketBeat
New York State Common Retirement Fund Sells 8,026,750 Shares of Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Understanding the Setup: (IONS) and Scalable Risk - Stock Traders Daily
Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Promising 9.68% Upside in the Biotech Arena - DirectorsTalk Interviews
Insider Sell: Eugene Schneider Sells Shares of Ionis Pharmaceuti - GuruFocus
Ionis Pharma EVP Baroldi sells $439k in shares By Investing.com - Investing.com Nigeria
Ionis Pharma EVP Birchler sells $513,047 in IONS stock By Investing.com - Investing.com Canada
Ionis pharma EVP Swayze sells $512k in IONS stock By Investing.com - Investing.com Canada
Ionis Pharma CFO Hougen sells $581k in shares By Investing.com - Investing.com Canada
Ionis Pharma EVP Baroldi sells $439k in shares - Investing.com
Eric Swayze Sells 6,179 Shares of Ionis Pharmaceuticals (NASDAQ:IONS) Stock - MarketBeat
Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells 5,885 Shares of Stock - MarketBeat
Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) CEO Sells 62,970 Shares of Stock - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) EVP Elizabeth Hougen Sells 6,988 Shares - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) EVP Brian Birchler Sells 6,179 Shares - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) EVP Eugene Schneider Sells 6,179 Shares - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells 6,179 Shares - MarketBeat
Ionis Pharma EVP O’Neil sells $516k in shares By Investing.com - Investing.com Canada
Ionis Pharma CEO Monia sells $5.2 million in shares By Investing.com - Investing.com Canada
Ionis Pharma EVP Schneider sells $515k in shares By Investing.com - Investing.com Canada
Profit Recap: Can Ionis Pharmaceuticals Inc be recession proofQuarterly Market Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
Barclays’ Supportive View on Ionis’s RNA Pipeline and Partnerships Might Change The Case For Investing In Ionis Pharmaceuticals (IONS) - Sahm
Privium Fund Management B.V. Sells 18,700 Shares of Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Lisanti Capital Growth LLC Acquires Shares of 92,124 Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Ionis announces proposed convertible offering to refinance 2026 convertible notes - MSN
Ionis Pharmaceuticals, Inc. $IONS Shares Sold by Great Lakes Advisors LLC - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) Earns Overweight Rating from Analysts at Barclays - MarketBeat
Ionis and Otsuka score EU nod for DAWNZERA, offering new hope for rare HAE patients - Indian Pharma Post
Is Ionis Pharmaceuticals Inc a top pick in the sectorQuarterly Earnings Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 12.94% Potential Upside Amidst Robust Pipeline - DirectorsTalk Interviews
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):